ACCESS-OSA: a randomized controlled trial for accurate, accessible, and cost-effective screening solutions for obstructive sleep apnoea: study protocol
Open Access
- 8 January 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (1)
Abstract
Obstructive sleep apnoea (OSA) is common and burdensome, yet current diagnostic pathways remain costly and often misclassify patients. Single-night polysomnography (PSG), the diagnostic gold standard, fails to capture night-to-night variability in severity, is difficult to access and costly. Emerging technologies enable multi-night in-home evaluation, but robust comparative evidence regarding accuracy and cost-effectiveness is lacking. This study will evaluate (a) the diagnostic accuracy of three multi-night in-home devices versus conventional single night PSG; (b) the patient and signal characteristics that optimize diagnostic performance; and (c) the cost-effectiveness of these pathways for clinical implementation. We will conduct a three-arm randomized diagnostic strategy trial (n = 500) enrolling adults referred for suspected OSA over a recruitment period of several years from July 2025. All participants will undergo both conventional single-night PSG and multi-night assessment with an under-mattress sensor, oximetry ring, and forehead EEG device. Participants will be randomized to one of three diagnostic pathways, determining the order in which sleep physicians interpret test results. Sleep physicians will provide sequential diagnostic decisions at each stage, and a blinded expert panel will determine consensus diagnoses. The primary outcome is diagnostic accuracy of each pathway compared with consensus diagnosis. Secondary outcomes include cost-effectiveness, patient-reported acceptability, clinical confidence, self-reported long-term symptoms, and health and quality of life outcomes over 12 months follow-up. Findings will provide definitive evidence for whether simplified and accessible multi-night testing can improve accuracy and cost-effectiveness of OSA diagnosis in routine care.Keywords
Funding Information
- Medical Research Future Fund
- 2024 MRFF Optimising Screening Diagnosis and Management of Obstructive Sleep Apnoea Stream 1 (2035741)
- Southern Adelaide Local Health Network
- Central Adelaide Local Health Network
- Institute for Breathing and Sleep
- Austin Health
- Australasian Sleep Association
- Sleep Health Foundation
- Sleep Disorders Australia
This publication has 67 references indexed in Scilit:
- Detection of sleep apnea using only inertial measurement unit signals from apple watch: a pilot-study with machine learning approachSleep and Breathing, 2025
- Can arterial tonometry-based detection of obstructive sleep apnea be a promising alternative for home sleep apnea tests?Sleep and Biological Rhythms, 2025
- Evaluating Somfit’s pulse arterial tonometry for detection of obstructive sleep apnoeaSleep and Biological Rhythms, 2024
- Patient preference of level I, II and III sleep diagnostic tests to diagnose obstructive sleep apnoea among pregnant women in early to mid-gestationSleep and Breathing, 2024
- OSA Pathogenesis2023
- Evaluating an under-mattress sleep monitor compared to a peripheral arterial tonometry home sleep apnea test device in the diagnosis of obstructive sleep apneaSleep and Breathing, 2022
- Sleep position, patient comfort, and technical performance with two established procedures for home sleep testingSleep and Breathing, 2021
- Association between obstructive sleep apnea and health-related quality of life in untreated adults: a systematic reviewSleep and Breathing, 2021
- Detecting central sleep apnea in adult patients using WatchPAT—a multicenter validation studySleep and Breathing, 2019
- Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of HypertensionJAMA, 2012